Top 6 Companies Revolutionising the Global Contract Development and Manufacturing Organisation (CDMO) Market

Catalent, Inc., Boehringer Ingelheim International GmbH, Recipharm AB, Curia, Pfizer Inc., and Jubilant Pharma Ltd, among others, are the significant players in the global contract development and manufacturing organisation (CDMO) market.

The global contract development and manufacturing organisation (CDMO) market is expected to grow in the forecast period of 2023-2028 at a CAGR of 8.4%. As per the analysis by Expert Market Research, the increasing demand for pharmaceutical products is driving the global CDMO market.

CDMOs optimise the supply chain and enhance the marketing capabilities of pharmaceutical companies to enable the rapid development of new and effective drugs, hence bolstering the market. The growing global population and the increasing prevalence of acute and chronic diseases are boosting the demand for pharmaceutical products in the market, which is also propelling the growth of the CDMO market. The increasing investment in research and development activities in drugs and manufacturing by CDMOs is further augmenting the market growth. With the increasing advancements in nuclear medicines and gene therapy, the demand for CDMOs is expected to grow over the forecast period.

North America is one of the leading regions in the CDMO market owing to the wide presence of various leading companies. The growing focus on innovations in the pharmaceutical sector in the region is likely to further increase the demand for CDMOs. Meanwhile, the Asia Pacific is expected to witness a rapid growth rate in the forecast period due to the increasing outsourcing in the region owing to the presence of a workforce with high skills and lower cost advantage in the research and development activities.

The increasing merger and acquisition activities by the leading companies are expected to boost the market growth. In August 2022, Catalent, Inc. reached an agreement to acquire Metrics Contract Services for USD 475 million from Mayne Pharma Group Limited. Through the acquisition, the company aims to boost its capabilities in the development, packaging, and manufacturing of integrated oral solids.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 6 Contract Development and Manufacturing Organisation (CDMO) Companies in the World

Catalent, Inc.

Catalent Inc. is a leading drug delivery and development company that supports the manufacturing and development of novel treatments in the pharmaceuticals sector. The company offers deep-scale and broad expertise in delivery technologies, development science, and multi-modality manufacturing. Over 19,000 workforce of the company supports the launch of more than 150 new products and acceleration of above 1000 partner programs each year. The company’s revenue in 2021 reached USD 4 billion.

Boehringer Ingelheim International GmbH

Boehringer Ingelheim international is one of the major pharmaceutical companies in the world. The company offers innovative healthcare solutions across various branches of medical science such as oncology, respiratory, cardiovascular, immunology, central nervous system, metabolic diseases and retinal health. With over 52,000 employees, the company serves more than 130 markets. Its major business areas include Animal Health, Human Pharma, and Biopharmaceutical Contract Manufacturing.

Recipharm AB

Recipharm AB is one of the world’s five largest pharmaceutical contract development and manufacturing organisations. The company offers its services in drug delivery devices, drug substances, and drug products. It provides support to pharmaceutical companies with early developments of products as well as their commercial production. It employs more than 9,000 people in 10 countries, serving over 100 markets.

Curia

Curia, formerly known as Albany Molecular Research (AMRI), is one of the most significant global CDMOs that offers its services to the biopharmaceuticals and pharmaceuticals sectors. The company offers advanced commercial manufacturing and R&D capabilities to enable advancements in new biopharmaceutical and pharmaceutical products. It has an employee base of 3000 in 21 locations across Europe, Asia, and the United States.

Pfizer Inc.

Pfizer Inc. is one of the world’s leading research-based biopharmaceutical companies that aims to improve representation and reduce health disparities by analysing its clinical trial data. It develops and produces medicines and vaccines for various branches like immunology, oncology, cardiology, endocrinology, and neurology, among others. It was one of the forerunners in developing an effective vaccine to prevent COVID-19. The company has around 79,000 employees worldwide and attained revenue of USD 81.3 billion in 2021.

Jubilant Pharmova

Jubilant Pharmova is a global pharmaceutical company that is involved in pharmaceuticals, proprietary novel drugs, and contract research and development services. Based out of Noida in Uttar Pradesh, it has about 6,000 employees across the globe and aims to offer cost-effective innovative products and services addressing unmet medical demands. The company’s products are marketed and sold in more than 85 countries. In 2021, the company generated revenue of INR 60,985 million from its operations.

Also Read@ https://www.expertmarketresearch.com/pressrelease/global-contract-development-and-manufacturing-organization-cdmo-market